Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
-
Published:2023-01
Issue:
Volume:178
Page:205-215
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Sheng Xinan, Ye Dingwei, Zhou Aiping, Yao Xin, Luo Hong, He Zhisong, Wang Zengjun, Zhao YingchaoORCID, Ji Zhigang, Zou Qing, He Chaohong, Guo Jianming, Tu Xinhua, Liu Ziling, Shi Benkang, Liu Ben, Chen Peng, Wei Qiang, Hu Zhiquan, Zhang Yanqiao, Jiang Kui, Zhou Fangjian, Wu Dapeng, Fu Cheng, Li Xingya, Wu Bin, Wang Lijie, Qin Shukui, Li Gang, Liu Yunpeng, Guo Hongqian, Chen Kehe, Zhang Dahong, Wang Gongxian, Ding Lieming, Wang Yang, Yuan Xiaobin, Guo Jun
Funder
Betta Pharmaceuticals
Subject
Cancer Research,Oncology
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|